Spotlight -

Downstream Processing|

Upstream Processing

|Articles|June 1, 2003

BioPharm International

BioPharm International-06-02-2003
Volume 2003 Supplement
Issue 1

Part 4: Culture Media, Biotechnology Products, and Vaccines

Author(s)Gail Sofer

by Gail Sofer, BioReliance

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 22 years ago

Article

Part 1: Skin, Bone, and Cells

over 22 years ago

Article

BioPharm International's Virus Inactivation Series: A Preface

over 22 years ago

Article

Inactivation of Viruses: An Introduction to the Series

over 22 years ago

Article

Part 3b: Plasma and Plasma Products (Treatments Other than Heat or Solvent/Detergent)

over 22 years ago

Article

Part 6: Inactivation Methods Grouped by Virus

over 22 years ago

Article

Part 3a: Plasma and Plasma Products (Heat and Solvent/Detergent Treatments)

over 22 years ago

Article

Part 5: Disinfection

over 22 years ago

Article

Part 2: Red Blood Cells and Platelets

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Trending on BioPharm International

Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs

How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia

Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms

Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care

© 2025 MJH Life Sciences^®

All rights reserved.